APA (7th ed.) Citation

Yang, Z., Xiao, H., Li, X., Wei, Z., Kang, M., Wang, R., & Huang, J. Antiangiogenic therapy with recombinant human endostatin may improve blood perfusion of cervical node with necrosis in nasopharyngeal carcinoma patients: A preliminary study by using contrast-enhanced ultrasound. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Yang, Zhendong, Huimin Xiao, Xigui Li, Zhuxin Wei, Min Kang, Rensheng Wang, and Jianyuan Huang. Antiangiogenic Therapy with Recombinant Human Endostatin May Improve Blood Perfusion of Cervical Node with Necrosis in Nasopharyngeal Carcinoma Patients: A Preliminary Study by Using Contrast-enhanced Ultrasound. Frontiers Media S.A.

MLA (9th ed.) Citation

Yang, Zhendong, et al. Antiangiogenic Therapy with Recombinant Human Endostatin May Improve Blood Perfusion of Cervical Node with Necrosis in Nasopharyngeal Carcinoma Patients: A Preliminary Study by Using Contrast-enhanced Ultrasound. Frontiers Media S.A.